Bayer HealthCare / Press

Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban Study in Patients with a recent Embolic Stroke of Undetermined Source

The study will investigate the benefits of the once-daily, novel oral anticoagulant rivaroxaban in approximately 7,000 patients with a recent embolic stroke of undetermined source (ESUS). more      

In Focus

Healthcare News

Photos & Videos

  • Photos

    Photo galleries with topic-related images.

  • TV Footage

    In this section you can find videos for editorial coverage.

Bayer HealthCare Links

Annual report Integrated Annual Report of Bayer AG 2013
RSS Feed
RSS Feed

Copyright © Bayer HealthCare AG